Aadi Bioscience, Inc. (AADI)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Aadi Bioscience, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Aadi Bioscience, Inc. (AADI) has returned 42.56% so far this year and 93.82% over the past 12 months.

Based on dividend-adjusted daily data since Aug 8, 2017, AADI's average daily return is +0.01%, while the average monthly return is -0.49%.

Historically, 44% of months were positive and 56% were negative. The best month was Jan 2019 with a return of +104.7%, while the worst month was Mar 2019 at -69.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 6 months.

On a daily basis, AADI closed higher 45% of trading days. The best single day was Jul 8, 2021 with a return of +63.2%, while the worst single day was Mar 18, 2019 at -71.3%.

Aadi Bioscience, Inc. has an annualized alpha of -6.11%, beta of 0.64, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since August 09, 2017.

• This stock participated in 121.96% of S&P 500 Index downside but only -37.54% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.64 may look defensive, but with R² of 0.02 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

AADI ranks 81 for risk / return — in the top 81% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Aadi Bioscience, Inc. (AADI) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Aadi Bioscience, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aadi Bioscience, Inc. was 98.67%, occurring on Jul 2, 2024. The portfolio has not yet recovered.

The current Aadi Bioscience, Inc. drawdown is 96.52%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Aadi Bioscience, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Aadi Bioscience, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.